Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking a Director of State Reimbursement Policy to lead efforts in state government affairs. This pivotal role involves collaborating with a dedicated team to shape strategic messaging around critical policy issues like drug pricing and reimbursement. The ideal candidate will bring extensive experience in policy development and government affairs, coupled with strong communication and project management skills. Join a forward-thinking organization committed to improving healthcare access and outcomes for patients worldwide. If you're ready to make a significant impact in the biopharmaceutical sector, this opportunity is for you.
New Mexico Legislative Finance Committee
Starting Range: $80,458-$95,720, depending on experience.
Washington, D.C., or Foster City, Calif.
The Director of State Reimbursement Policy will facilitate the execution of state government affairs policy priorities related to Gilead’s pharmacy dispensed products. This person will work collaboratively with the State Government Affairs (SGA) team to help the state team develop strategic positioning and messaging related to core policy competencies in the areas of drug pricing, price transparency, value, innovative payment models, reimbursement, coverage and key therapeutic area policies, such as HIV, liver disease and COVID-19. The position requires the integration of political, policy and government affairs expertise to develop and execute effective, proactive strategies.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, Calif., Gilead has operations in North, South and Central America, Europe, Africa, Asia and Australia. Gilead makes it a priority to increase access to its medicines for people who can benefit from them, regardless of where they live or their economic status.
Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S., Canada, Australia, Singapore and Hong Kong employees and contractors to receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.
For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.
For jobs in the United States:
As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers@gilead.com for assistance.